Clopidogrel Resistance: Implications for Coronary Stenting

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|10|1261-1269

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.10, 2006-04, pp. : 1261-1269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel an alternative to ticlopidine in coronary stenting

By  

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Clopidogrel + eptifibatide CLEARs PLATELETS after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Clopidogrel vs ticlopidine: tolerability after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Clopidogrel: The Future Choice for Preventing Platelet Activation During Coronary Stenting?

By Gurbel P.A.   O'connor C.M.   Cummings C.C.   Serebruany V.L.  

Pharmacological Research, Vol. 40, Iss. 2, 1999-08 ,pp. : 107-111

Academic Press

Access to resources Recommend Favorite

Clopidogrel: Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome after coronary stenting: case report

By  

Reactions Weekly, Vol. 1, Iss. 1012, 2004-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite